Question · asked by 1 review

Caffeine vs other methylxanthines: c) Developmental delay more than two SDs below population mean on a standardized test of development: motor delay № of participants: 79(1 RCT)

It is very uncertain whether caffeine changes c) Developmental delay more than two SDs below population mean on a… compared with other methylxanthines (very low certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Caffeine vs other methylxanthines
c) Developmental delay more than two SDs below population mean on a standardized test of development: motor delay № of participants: 79(1 RCT) · preterm infants
It is very uncertain whether caffeine changes c) Developmental delay more than two SDs below population mean on a… compared with other methylxanthines (very low certainty).
Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants (2023) · Cochrane Headline outcomes only
RR 0.5 [0.13, 1.96]Not reportedVery low

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Caffeine versus other methylxanthines for the prevention and treatment of apnea in preterm infants
2023 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.